Oncopharmpod
Glofitamab & TALAPRO - 2
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:12:59
- More information
Informações:
Synopsis
This week's Pod looks at the 2nd CD20-CD3 bispecific T-Cell engager approved this year (or at all), glofitamab, and the TALAPRO-2 study of combining talazoparib to enzalutaimide. TALAPRO-2: https://doi.org/10.1016/S0140-6736(23)01055-3
